Sodium arsenite downregulates transcriptional activity of AP-1 and CRE binding proteins in IL-1β-treated Caco-2 cells by increasing the expression of the transcriptional repressor CREMα

Dan D. Hershko, Bruce Robb, Guang Jo Luo, Eric S. Hungness, Per Olof Hasselgren

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

In recent studies, sodium arsenite (SA) inhibited IL-6 production in cultured intestinal epithelial cells, at least in part by downregulating the activity of nuclear factor-kappaB (NF-κB). The influence of SA on the activity of other transcription factors regulating the interleukin-6 (IL-6) gene in enterocytes is not known. We tested the effect of SA on the activity of CCAAT/enhancer binding protein (C/EBP), activating protein-1 (AP-1), and CRE binding proteins in IL-1βtreated Caco-2 cells. DNA binding activity was determined by electrophoretic mobility shift assay (EMSA) and transcriptional activity by transfecting cells with luciferase reporter plasmids containing promoter constructs with binding sites for the individual transcription factors. DNA binding activity for all three transcription factors was increased after treatment with SA or IL-1β. In contrast, SA inhibited transcriptional activity of AP-1 and CRE binding proteins but not C/EBP. Additional experiments provided evidence that the inhibition of AP-1 and CRE mediated transcriptional activity was associated with, and probably caused by, increased expression of the transcriptional repressor cyclic AMP response element modulator (CREM)α. The present results are consistent with the concept that SA inhibits IL-6 production in stimulated enterocytes by downregulating the transcriptional activity of several, but not all, IL-6-related transcription factors. Because of the multiple important biological functions of IL-6 in the enterocyte and gut mucosa, methods to regulate enterocyte IL-6 production have significant clinical implications.

Original languageEnglish (US)
Pages (from-to)627-640
Number of pages14
JournalJournal of Cellular Biochemistry
Volume90
Issue number3
DOIs
StatePublished - Oct 15 2003
Externally publishedYes

Fingerprint

Cyclic AMP Response Element Modulator
Activating Transcription Factor 2
Caco-2 Cells
Interleukin-1
Interleukin-6
Down-Regulation
Enterocytes
Proteins
Transcription Factors
CCAAT-Enhancer-Binding Proteins
Electrophoretic mobility
DNA
Electrophoretic Mobility Shift Assay
Luciferases
sodium arsenite
Assays
Mucous Membrane
Plasmids
Genes
Epithelial Cells

Keywords

  • Cytokines
  • Enterocytes
  • IL-6
  • Intestine
  • Mucosa
  • Sodium arsenite
  • Transcription factors

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology

Cite this

Sodium arsenite downregulates transcriptional activity of AP-1 and CRE binding proteins in IL-1β-treated Caco-2 cells by increasing the expression of the transcriptional repressor CREMα. / Hershko, Dan D.; Robb, Bruce; Luo, Guang Jo; Hungness, Eric S.; Hasselgren, Per Olof.

In: Journal of Cellular Biochemistry, Vol. 90, No. 3, 15.10.2003, p. 627-640.

Research output: Contribution to journalArticle

@article{420bb0da9858405386c28c1b2278d422,
title = "Sodium arsenite downregulates transcriptional activity of AP-1 and CRE binding proteins in IL-1β-treated Caco-2 cells by increasing the expression of the transcriptional repressor CREMα",
abstract = "In recent studies, sodium arsenite (SA) inhibited IL-6 production in cultured intestinal epithelial cells, at least in part by downregulating the activity of nuclear factor-kappaB (NF-κB). The influence of SA on the activity of other transcription factors regulating the interleukin-6 (IL-6) gene in enterocytes is not known. We tested the effect of SA on the activity of CCAAT/enhancer binding protein (C/EBP), activating protein-1 (AP-1), and CRE binding proteins in IL-1βtreated Caco-2 cells. DNA binding activity was determined by electrophoretic mobility shift assay (EMSA) and transcriptional activity by transfecting cells with luciferase reporter plasmids containing promoter constructs with binding sites for the individual transcription factors. DNA binding activity for all three transcription factors was increased after treatment with SA or IL-1β. In contrast, SA inhibited transcriptional activity of AP-1 and CRE binding proteins but not C/EBP. Additional experiments provided evidence that the inhibition of AP-1 and CRE mediated transcriptional activity was associated with, and probably caused by, increased expression of the transcriptional repressor cyclic AMP response element modulator (CREM)α. The present results are consistent with the concept that SA inhibits IL-6 production in stimulated enterocytes by downregulating the transcriptional activity of several, but not all, IL-6-related transcription factors. Because of the multiple important biological functions of IL-6 in the enterocyte and gut mucosa, methods to regulate enterocyte IL-6 production have significant clinical implications.",
keywords = "Cytokines, Enterocytes, IL-6, Intestine, Mucosa, Sodium arsenite, Transcription factors",
author = "Hershko, {Dan D.} and Bruce Robb and Luo, {Guang Jo} and Hungness, {Eric S.} and Hasselgren, {Per Olof}",
year = "2003",
month = "10",
day = "15",
doi = "10.1002/jcb.10654",
language = "English (US)",
volume = "90",
pages = "627--640",
journal = "Journal of Cellular Biochemistry",
issn = "0730-2312",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Sodium arsenite downregulates transcriptional activity of AP-1 and CRE binding proteins in IL-1β-treated Caco-2 cells by increasing the expression of the transcriptional repressor CREMα

AU - Hershko, Dan D.

AU - Robb, Bruce

AU - Luo, Guang Jo

AU - Hungness, Eric S.

AU - Hasselgren, Per Olof

PY - 2003/10/15

Y1 - 2003/10/15

N2 - In recent studies, sodium arsenite (SA) inhibited IL-6 production in cultured intestinal epithelial cells, at least in part by downregulating the activity of nuclear factor-kappaB (NF-κB). The influence of SA on the activity of other transcription factors regulating the interleukin-6 (IL-6) gene in enterocytes is not known. We tested the effect of SA on the activity of CCAAT/enhancer binding protein (C/EBP), activating protein-1 (AP-1), and CRE binding proteins in IL-1βtreated Caco-2 cells. DNA binding activity was determined by electrophoretic mobility shift assay (EMSA) and transcriptional activity by transfecting cells with luciferase reporter plasmids containing promoter constructs with binding sites for the individual transcription factors. DNA binding activity for all three transcription factors was increased after treatment with SA or IL-1β. In contrast, SA inhibited transcriptional activity of AP-1 and CRE binding proteins but not C/EBP. Additional experiments provided evidence that the inhibition of AP-1 and CRE mediated transcriptional activity was associated with, and probably caused by, increased expression of the transcriptional repressor cyclic AMP response element modulator (CREM)α. The present results are consistent with the concept that SA inhibits IL-6 production in stimulated enterocytes by downregulating the transcriptional activity of several, but not all, IL-6-related transcription factors. Because of the multiple important biological functions of IL-6 in the enterocyte and gut mucosa, methods to regulate enterocyte IL-6 production have significant clinical implications.

AB - In recent studies, sodium arsenite (SA) inhibited IL-6 production in cultured intestinal epithelial cells, at least in part by downregulating the activity of nuclear factor-kappaB (NF-κB). The influence of SA on the activity of other transcription factors regulating the interleukin-6 (IL-6) gene in enterocytes is not known. We tested the effect of SA on the activity of CCAAT/enhancer binding protein (C/EBP), activating protein-1 (AP-1), and CRE binding proteins in IL-1βtreated Caco-2 cells. DNA binding activity was determined by electrophoretic mobility shift assay (EMSA) and transcriptional activity by transfecting cells with luciferase reporter plasmids containing promoter constructs with binding sites for the individual transcription factors. DNA binding activity for all three transcription factors was increased after treatment with SA or IL-1β. In contrast, SA inhibited transcriptional activity of AP-1 and CRE binding proteins but not C/EBP. Additional experiments provided evidence that the inhibition of AP-1 and CRE mediated transcriptional activity was associated with, and probably caused by, increased expression of the transcriptional repressor cyclic AMP response element modulator (CREM)α. The present results are consistent with the concept that SA inhibits IL-6 production in stimulated enterocytes by downregulating the transcriptional activity of several, but not all, IL-6-related transcription factors. Because of the multiple important biological functions of IL-6 in the enterocyte and gut mucosa, methods to regulate enterocyte IL-6 production have significant clinical implications.

KW - Cytokines

KW - Enterocytes

KW - IL-6

KW - Intestine

KW - Mucosa

KW - Sodium arsenite

KW - Transcription factors

UR - http://www.scopus.com/inward/record.url?scp=0141918849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141918849&partnerID=8YFLogxK

U2 - 10.1002/jcb.10654

DO - 10.1002/jcb.10654

M3 - Article

C2 - 14523996

AN - SCOPUS:0141918849

VL - 90

SP - 627

EP - 640

JO - Journal of Cellular Biochemistry

JF - Journal of Cellular Biochemistry

SN - 0730-2312

IS - 3

ER -